VPM will be present at the "15. DVMD-Fachtagung: Brücken bauen zwischen Medizin, Informatik, Biometrie und Epidemiologie" which will take place in Düsseldorf on 05-06 March, 2019.
VPM will speak during the VaxInLive 2019 Symposium, that will take place at the University of Antwerp from 27th February until 1st March 2019.
VPM will be present at the "Successful R&I in Europe 2019: 10th European Networking Event" which will take place in Düsseldorf on 14-15 February, 2019.
VPM will speak during a Rebirth special lecture, that will take place in the Hannover Medical School (Lecture Hall M,I1) on 12. February 2019, 5:00 pm.
VPM was invited to join the TBVI (TuBerculosis Vaccine Initiative) Annual Symposium which was held on 29th of January until 31th of January 2019 in Les Diablerets, Switzerland.
From 28. to 29.11.2018, VPM organized a kick off meeting in Johannesburg, South Africa, for a pivotal VPM1002 phase III trial to be conducted in newborn infants in South Africa, Tanzania, Kenya, Uganda and Gabon.
This year's conference topic is "15 Years VPM - from Target to Market". The presentations during the event will address critical factors for successful translational research and development.
First results of the VPM1002BC clinical Phase I/II study will be presented at the international congress of the European Association of Urology 2018 in Copenhagen, Denmark that will take place from 16. to 20.03.2018.
VPM will speak during the 2018 PDA Europe Vaccines conference in Malaga, Spain that will take place from 24. to 25.04.2018.
VPM will speak during the 8th Annual Vaccine World Summit 2018 in Pune India, that will take place from 20. to 21.02.2018.